Lv11
30 积分 2022-02-16 加入
CD19 CAR-T treatment shows limited efficacy in r/r DLBCL with double expression and TP53 alterations
1小时前
已完结
How I treat HLH-like toxicities after immune effector cell therapy
1个月前
已关闭
Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter, prospective, observational study in China
1个月前
已完结
Multi-centers experience using therapeutic plasma exchange for corticosteroid/tocilizumab-refractory cytokine release syndrome following CAR-T therapy
2个月前
已完结
How I Treat HLH-Like Toxicities Following Immune Effector Cell Therapy
5个月前
已关闭
Clinical and Cytokine Features of Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome
5个月前
已完结
Daratumumab for eradication of minimal residual disease in high-risk advanced relapse of T-cell/CD19/CD22-negative acute lymphoblastic leukemia
5个月前
已完结
Triplet Therapies in Chronic Lymphocytic Leukemia
6个月前
已完结
Cytokine release syndrome and neurotoxicity following CAR T-cell therapy for hematologic malignancies
6个月前
已完结
The role of cytokines in cytokine release syndrome (CRS) after CAR T cell therapy
6个月前
已关闭
皖公网安备34019202002308
